Market Pulse Archives

Nov. 30, 2021, 9:33 a.m. EST

Dow skids over 200 points lower at Tuesday's open as Moderna CEO raises doubt about current batch of vaccines versus omicron

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Moderna Inc. (MRNA)
  • X
    Dow Jones Industrial Average (DJIA)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Mark Decambre

U.S. stock benchmarks headed lower Tuesday morning, giving up some of Monday's gains, amid fresh concerns that the new omicron strain of coronavirus is more resistant to the current batch of vaccines. Moderna /zigman2/quotes/205619834/composite MRNA -4.45% Chief Executive Stéphane Bancel told the Financial Times in an interview. The Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.30% was down 0.8%, the S&P 500 index /zigman2/quotes/210599714/realtime SPX -1.89% declined 0.6% at 4,627, while the Nasdaq Composite Index /zigman2/quotes/210598365/realtime COMP -2.72% retreated 0.4% at 15,717. The 10-year benchmark Treasury note was yielding 1.44%, down from 1.529% on Monday at 3 p.m. Eastern Time.

/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 160.07
-7.45 -4.45%
Volume: 11.80M
Jan. 21, 2022 4:00p
P/E Ratio
9.83
Dividend Yield
N/A
Market Cap
$64.90 billion
Rev. per Employee
$9.10M
loading...
/zigman2/quotes/210598065/realtime
US : Dow Jones Global
34,265.37
-450.02 -1.30%
Volume: 523.88M
Jan. 21, 2022 4:52p
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,397.94
-84.79 -1.89%
Volume: 3.20B
Jan. 21, 2022 4:52p
loading...
/zigman2/quotes/210598365/realtime
US : Nasdaq
13,768.92
-385.10 -2.72%
Volume: 5.01M
Jan. 21, 2022 5:16p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.